Cite
MLA Citation
Allen Li et al.. “Exceptional Response to Pembrolizumab and Trastuzumab in a Heavily Pretreated Patient With HER2-Positive TMB-H and MSI-H Metastatic Breast Cancer.” JCO precision oncology, vol. 5, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100150611398.0x000006